Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-016-1258-8
Published Online: 2016-03-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Shaoyong
Liu, Xiangyang
Ming, Jie
Ji, Qiuhe
Funding for this research was provided by:
AstraZeneca (ESR-14-10319)